Table 3. Revised EUCAST v.12.0 clinical breakpoints
Ann Clin Microbiol 2022;25:67-72. EUCAST v.12.0 review focused on changes Download table (A) Disk diffusion method: revised zone diameter breakpoints (mm), ATU Organism Antimicrobial agent S ≥ R < ATU P. aeruginosa Meropenem (indications other than meningitis) 20 14 – Meropenem (meningitis) 20 20 Pseudomonasspp. Levofloxacin 50 18 S. epidermidisand S.lugdunensis Cefoxitin (screen only) 27 […]
Table 1. Resistance to carbapenem and ciprofloxacin with corresponding resistance genes
Ann Clin Microbiol 2022;25:53-59. Current prevalence of the crpP gene in carbapenemase-producing Pseudomonas aeruginosa blood isolates in Korea Download table Isolates Phenotype (ZD) Genotype IPM MEM CIP CRP PMQR gyrA parC F0020PA0023 R (11) R (10) R (6) blaGES-9 aac(6′)-Ib-cr Thr83Ile Ser87Leu A0020PA0022 R (7) R (6) R (6) blaGES-5 aac(6′)-Ib-cr, crpP Thr83Ile Ser87Leu A0020PA0005 […]
Table 1. Comparison between CA-CDI and HA-CDI groups
Ann Clin Microbiol 2022;25:47-52. Clinical and microbiological risk factors for community-associated Clostridioides difficile infections Download table Variables CA-CDI (n = 127) HA-CDI (n = 265) P-value Age (yr) 66.9±18.9 72.1±13.5 0.0064 Sex, male 51 (40.2) 120 (45.3) 0.3386 Charlson comorbidity index 2.4±2.1 2.7±1.9 0.1109 Associated disease Biliary tract disease 3 (2.4) 8 (3.0) 0.7133 Cancer […]
Table 2. Patient characteristics of four cases with UL54 mutations alone
Ann Clin Microbiol 2022;25:41-46. Antiviral resistance in human cytomegalovirus due to UL54 mutations without UL97 mutations Download table Patient No. Sex Age (yr) Underlying disease CMV disease Outcome UL54 mutations 6 Female 15 MDS, HaploPBSCT Pneumonia Retinitis Encephalitis Expired F412L 11 Female 18 AA, HaploPBSCT Pneumonia Encephalitis Expired V715M/L501I 14 Female 18 AA, HaploPBSCT Encephalitis […]
Table 1. Human cytomegalovirus UL97/UL54 gene mutations observed in this study
Ann Clin Microbiol 2022;25:41-46. Antiviral resistance in human cytomegalovirus due to UL54 mutations without UL97 mutations Download table Case No. Year UL97 mutations (specimen) UL54 mutations (specimen) Viral loads 3 2019 A594P (blood) – 4.12 log IU/mL 6 2018 – F412L (blood) 3.03 log IU/mL 7 2018 L595F (blood) N408D (blood) 4.40 log copies/mL 11 […]
Table 1. Antibiotic resistance profiles of Acinetobacter baumanii, ESBL E.coli and Klebsiella pneumonia
Ann Clin Microbiol 2022;25:31-39. Inhibitory effects of copper, brass, and stainless steel surfaces on multidrug-resistant microorganisms Download table Clinical isolates AZT CAZ CFT CPE IMP GM SXT TGC TZP AM AMC AN CFX CIP CZ ETP AS CL CP MER MI PI TIM A. baumannii Isolate-1 R R R R R R S S R […]
Table 2. Risk factors for severe or severe complicated CDI over non-severe CDI: a multivariate analysis
Ann Clin Microbiol 2022;25:17-23. Clinical and microbiological risk factors for severe Clostridioides difficile infections Download table Risk factor OR (95% CI) P-value* Advanced age 1.017 (1.001-1.034) 0.0358 History of chemotherapy 2.695 (1.016-7.146) 0.0464 Ribotype 002 3.406 (1.183-9.803) 0.0231 *Statistical significances were maintained after the adjustment for age, associated disease (cancer, pneumonia, heart failure, nutrition deficiency), […]
Table 1. Comparison of severe (or severe complicated) CDI and non-severe CDI
Ann Clin Microbiol 2022;25:17-23. Clinical and microbiological risk factors for severe Clostridioides difficile infections Download table Variable Severe or severe complicated CDI(n = 149) Non-severe CDI(n = 155) P-value Age (yr) 74.0+15.0 65.9+18.3 < 0.0001 Sex, male 70 (47.0) 70 (45.2) 0.7505 Hospital-associated 100 (67.1) 94 (60.7) 0.2411 Charlson comorbidity index 2.4+1.7 2.5+1.8 0.6365 Associated […]
Table 3. Clinical course of patients with confirmed Plasmodium vivax infections
Ann Clin Microbiol 2022;25:11-16. Genetic polymorphisms in the pvdhfr, pvmdr1, and pvdhps genes of Plasmodium vivax in patients at a secondary hospital in South Korea Download table Patient No. Medication Parasite count (/μL) [FU day*] Initial 1st FU 2nd FU 3rd FU 4th FU 5th FU 1 3 days of HCQ followed by 2 weeks […]
Table 2. Identified polymorphisms in pvdhfr of Plasmodium vivax
Ann Clin Microbiol 2022;25:11-16. Genetic polymorphisms in the pvdhfr, pvmdr1, and pvdhps genes of Plasmodium vivax in patients at a secondary hospital in South Korea Download table Variants No. of cases pvdhfr F57L, C.292_309del 5 pvdhfr C.292_309del 2 pvdhfr H99S 3 pvdhfr S58R, S117N 1 pvdhfr C.292_309del & pvdhps M399I 1